Invitrogen have announced a contract to provide Locus Pharmaceuticals, Inc. with kinase screening services through its SelectScreen™ platform. Invitrogen's service will support Locus' internal kinase ...
The CYP2D6 enzyme metabolizes approximately 25% of commonly used pharmaceuticals and is of intense pharmacogenetic interest. Polymorphisms in CYP2D6 can alter an individual’s response to a wide range ...
In total, 29 blood samples were collected from members of the Pakistani family, a part of which lives in the UK and the others in Pakistan. Neurological assessment of the proband (IV.13; Figure 1) led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback